Canaccord Genuity Reiterates a 'Hold' on Amicus Therapeutics (FOLD); Q4/11 Update: Market Focus Shifts to Combo Therapy
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
12 Buy, 9 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Hold' on Amicus Therapeutics (NASDAQ: FOLD) price target of $10.00.
Analyst, Ritu Baral, said, "Reiterate rating and price target on potential positive migalastat pivotal Fabry monoTx data Q3/12, chaperone/ERT combo therapy for Fabry, apy for Fabry, Pompe. We think Q3/12 pivotal migalastat (fka Amigal) Fabry monotx ‘011’ trial data will be a strong positive, transformational catalyst. We think ‘011 has a high chance of success on Phase 2 precedent and trial enrichment. We also expect good top-line Phase 2 proof of concept AT2220/ERT Pompe combo data in H1/12, similar to recent positive Fabry combo data presented at WORLD."
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $6.88 yesterday.
Analyst, Ritu Baral, said, "Reiterate rating and price target on potential positive migalastat pivotal Fabry monoTx data Q3/12, chaperone/ERT combo therapy for Fabry, apy for Fabry, Pompe. We think Q3/12 pivotal migalastat (fka Amigal) Fabry monotx ‘011’ trial data will be a strong positive, transformational catalyst. We think ‘011 has a high chance of success on Phase 2 precedent and trial enrichment. We also expect good top-line Phase 2 proof of concept AT2220/ERT Pompe combo data in H1/12, similar to recent positive Fabry combo data presented at WORLD."
For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.
Shares of Amicus Therapeutics closed at $6.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
